Research Article
AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma
Table 1
Survival status and clinicopathological parameters in ADC specimens.
| Characteristics | Total | Survival status | value | Died, | Alive, |
| Gender | | | | 0.482 | Female | 37 | 21 | 16 | | Male | 38 | 25 | 13 | | Age (years) | | | | 0.482 | <60 | 37 | 21 | 16 | | ≥60 | 38 | 25 | 13 | | Tumor size (cm) | | | | 1.000 | ≤3 | 23 | 14 | 9 | | >3 | 52 | 32 | 20 | | Lymph node metastasis | | | | <0.001 | Absent | 37 | 15 | 22 | | Present | 38 | 31 | 7 | | Distant metastases | | | | 0.078 | Absent | 65 | 37 | 28 | | Present | 10 | 9 | 1 | | TNM stage | | | | 0.004 | I-II | 38 | 17 | 21 | | III-IV | 37 | 29 | 8 | | AHNAK2 expression | | | | 0.017 | Low | 35 | 16 | 19 | | High | 40 | 30 | 10 | |
|
|
Statistical analyses were performed by the Pearson test. was considered to be statistically significant. |